C-Path’s Predictive Safety Testing Consortium will be hosting its 3rd PSTC Japan Safety Biomarker Workshop on February 20, 2023 in Fujisawa, Japan.

The utilization of biomarkers in guiding drug development decisions through clinical trials and post marketing studies is increasing. This conference will explore the areas of cooperation in the clinical application of biomarkers and drug development tools and their qualification and share knowledge about safety biomarkers in drug development via speaker presentations and panel discussions. Representatives from academia, government and industry will participate. The workshop is co-sponsored by The Japan Society of Toxicology.

Learn more and register for the workshop here.